The Molecular Biology of Myeloma

David S. Siegel, MD, PhD
Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
January 20, 2016

Defining Cancer Stem Cells

Dr Gerson provides an overview of cancer stem cells.

December 12, 2016

Clinical Management for Relapsing Patients

Sunil Verma, MD, MSEd, FRCPC discusses all the patient factors when managing patients who relapse.